Loading…
Loading…
EQUITY / NASDAQ · XNMS
PomDoctor Ltd. ADR
No accepted understanding yet. Follow this company to establish research where evidence supports it.
Open research workspace →01/01/2025 – 12/31/2025 · CNY · Units
Reported figures establish facts for this period; they do not by themselves establish a profitability trend.
Open report ↗0.86 USD
Observed: 10/02/2026 · tickerlayer · Historical end-of-day close
Powered by TickerLayer
10/02/2026 · 0.86 USD · Volume 6,926
64 actual observations · Latest bar: 2026-10-02 · Market data is indicative; provider terms apply.
3 available financial reports
Research reports →SEC FINANCIAL REPORTS
01/01/2025 – 12/31/2025 · Units
| Metric | 2025 / Year end | 2024 / Year end | Change |
|---|---|---|---|
| Revenue | 399,914,964 CNY | 342,557,920 CNY | +16.74% |
| Operating profit | -118,634,820 CNY | -25,791,280 CNY | — |
| Net income | -130,931,921 CNY | -37,365,434 CNY | — |
| Operating cash flow | -148,479,652 CNY | -16,130,880 CNY | — |
| Cash and cash equivalents | 9,580,367 CNY | 7,651,695 CNY | +25.21% |
Changes are calculated only for matching period length, consolidation, currency, and scale. Percentages are not shown for zero or negative baselines.
Each column uses its report's scale. Check column headers before comparing different consolidation scopes and scales.
| Financial metric | 2025 / Year end01/01/2025 – 12/31/2025ConsolidatedUnits · CNY | 2024 / Year end01/01/2024 – 12/31/2024ConsolidatedUnits · CNY | 2023 / Year end01/01/2023 – 12/31/2023ConsolidatedUnits · CNY |
|---|---|---|---|
| Capital expendituresCash flow statement | 1,007,753 CNY | 37,773 CNY | 111,891 CNY |
| Cash and cash equivalentsBalance sheet | 9,580,367 CNY | 7,651,695 CNY | 6,717,031 CNY |
| Financing cash flowCash flow statement | 153,926,711 CNY | 17,016,080 CNY | 50,067,178 CNY |
| Gross profitIncome statement | 52,282,111 CNY | 47,694,053 CNY | 38,721,769 CNY |
| Investing cash flowCash flow statement | -1,607,753 CNY | -33,373 CNY | -111,891 CNY |
| Net incomeIncome statement | -130,931,921 CNY | -37,365,434 CNY | -36,949,421 CNY |
| Operating cash flowCash flow statement | -148,479,652 CNY | -16,130,880 CNY | -45,795,682 CNY |
| Operating profitIncome statement | -118,634,820 CNY | -25,791,280 CNY | -22,248,902 CNY |
| RevenueIncome statement | 399,914,964 CNY | 342,557,920 CNY | 304,852,971 CNY |
| Total assetsBalance sheet | 107,557,426 CNY | 46,227,586 CNY | — |
| Total equityBalance sheet | -453,971,266 CNY | -2,263,421,920 CNY | -2,120,063,475 CNY |
| Total liabilitiesBalance sheet | 588,854,087 CNY | 545,908,548 CNY | — |
| Report source | Open report ↗ Published: 05/14/2026 | Open report ↗ Published: 05/14/2026 | Open report ↗ Published: 05/14/2026 |
The latest available source version is shown for each period. Previous versions and correction relationships are not shown in this view.